Chemomab Therapeutics Ltd. Share Price
NASDAQ: CMMB | Micro Cap$1.12
+$1.12 (--%) Last updated on 30 Oct, 2026 | 01:22 ISTChemomab Therapeutics Ltd. Stock Performance
Chemomab Therapeutics Ltd. Share Price Chart
$1.12$1.12
L
H
Chemomab Therapeutics Ltd. Quarterly Profit & Loss
All figures in USD
Chemomab Therapeutics Ltd. Annual Profit & Loss
All figures in USD
About Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Chemomab Therapeutics Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.28 | $1.12 | -5.08% |
Sep 2026 | $2.70 | $1.18 | -56.13% |
Aug 2026 | $1.60 | $2.69 | +74.68% |
Jul 2026 | $1.73 | $1.54 | -3.14% |
Jun 2026 | $2.00 | $1.59 | -20.70% |
May 2026 | $1.57 | $2.00 | +35.47% |
Apr 2026 | $1.58 | $1.48 | -1.33% |
Mar 2026 | $1.85 | $1.50 | -15.73% |
Feb 2026 | $1.58 | $1.78 | +14.84% |
Jan 2026 | $1.76 | $1.55 | -5.49% |
Dec 2025 | $2.64 | $1.64 | -36.80% |
Nov 2025 | $3.00 | $2.60 | -15.88% |